Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Acetaminophen research

This article was originally published in The Tan Sheet

Executive Summary

High doses of analgesic clear "rapidly and completely" from the bloodstream, researchers state at Society of Toxicology annual meeting in Salt Lake City. "Analysis of plasma acetaminophen levels showed that doses as high as 8 g/day, or twice the maximum daily recommended dose, did not accumulate and the drug was consistently cleared from the bloodstream," according to McNeil's Cathy Gelotte, PhD. Double-blind, placebo-controlled study divided 36 participants into three groups with dosing regimens of 4 g/d, 6 g/d or 8 g/d for three days. Participants underwent blood sampling during the first and last dose of each daily regimen, Gelotte reports. NDAC members recently advised acetaminophen labeling changes to clarify potential for liver toxicity (1"The Tan Sheet" Sept. 23, 2002, p. 4)...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS095330

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel